Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| MDA-MB-231 | 17-AAG | 0.031623 | uM | 10 | 5000.00 | 2314.91 | 6611.00 | 6524.00 | 1.0133 | 1.0178 |
| MDA-MB-231 | Lapatinib | 0.1 | uM | 10 | 5000.00 | 2314.91 | 6681.00 | 6524.00 | 1.0241 | 1.0321 |
| MDA-MB-231 | Lapatinib | 0.031623 | uM | 10 | 5000.00 | 2314.91 | 6817.00 | 6524.00 | 1.0449 | 1.0597 |
| MDA-MB-231 | Linsitinib | 3.1623 | uM | 10 | 5000.00 | 2314.91 | 6295.00 | 6524.00 | 0.9649 | 0.9528 |
| MDA-MB-231 | 0 | uM | 10 | 5000.00 | 2314.91 | 6554.00 | 6524.00 | 1.0046 | 1.0061 | |
| MDA-MB-231 | Erlotinib | 0.1 | uM | 10 | 5000.00 | 2314.91 | 6669.00 | 6524.00 | 1.0222 | 1.0296 |
| MDA-MB-231 | Linsitinib | 0.31623 | uM | 10 | 5000.00 | 2314.91 | 6249.00 | 6524.00 | 0.9579 | 0.9432 |
| MDA-MB-231 | Linsitinib | 0.1 | uM | 10 | 5000.00 | 2314.91 | 6607.00 | 6524.00 | 1.0127 | 1.0170 |
| MDA-MB-231 | Erlotinib | 1 | uM | 10 | 5000.00 | 2314.91 | 6612.00 | 6524.00 | 1.0135 | 1.0180 |
| MDA-MB-231 | Linsitinib | 19.9526 | uM | 10 | 5000.00 | 2314.91 | 4877.00 | 6524.00 | 0.7476 | 0.6463 |
| MDA-MB-231 | Erlotinib | 0.031623 | uM | 10 | 5000.00 | 2314.91 | 6670.00 | 6524.00 | 1.0224 | 1.0298 |
| MDA-MB-231 | 0 | uM | 10 | 5000.00 | 2314.91 | 6490.00 | 6524.00 | 0.9948 | 0.9930 | |
| MDA-MB-231 | 17-AAG | 3.1623 | uM | 10 | 5000.00 | 2314.91 | 3705.00 | 6524.00 | 0.5679 | 0.3698 |
| MDA-MB-231 | 0 | uM | 10 | 5000.00 | 2314.91 | 6497.00 | 6524.00 | 0.9959 | 0.9945 | |
| MDA-MB-231 | 0 | uM | 10 | 5000.00 | 2314.91 | 6555.00 | 6524.00 | 1.0048 | 1.0064 | |
| MDA-MB-231 | 17-AAG | 10 | uM | 10 | 5000.00 | 2314.91 | 2570.00 | 6524.00 | 0.3939 | 0.0724 |
| MDA-MB-231 | 17-AAG | 0.0016596 | uM | 10 | 5000.00 | 2314.91 | 6397.00 | 6524.00 | 0.9805 | 0.9739 |
| MDA-MB-231 | Lapatinib | 0.0033113 | uM | 10 | 5000.00 | 2314.91 | 6587.00 | 6524.00 | 1.0097 | 1.0129 |
| MDA-MB-231 | Erlotinib | 0.01 | uM | 10 | 5000.00 | 2314.91 | 6570.00 | 6524.00 | 1.0071 | 1.0094 |
| MDA-MB-231 | 0 | uM | 10 | 5000.00 | 2314.91 | 6555.00 | 6524.00 | 1.0048 | 1.0064 | |
| MDA-MB-231 | Erlotinib | 3.1623 | uM | 10 | 5000.00 | 2314.91 | 6503.00 | 6524.00 | 0.9968 | 0.9957 |
| MDA-MB-231 | Lapatinib | 0.0016596 | uM | 10 | 5000.00 | 2314.91 | 6522.00 | 6524.00 | 0.9997 | 0.9996 |
| MDA-MB-231 | Linsitinib | 1 | uM | 10 | 5000.00 | 2314.91 | 6329.00 | 6524.00 | 0.9701 | 0.9598 |
| MDA-MB-231 | Lapatinib | 3.1623 | uM | 10 | 5000.00 | 2314.91 | 6180.00 | 6524.00 | 0.9473 | 0.9288 |
| MDA-MB-231 | Linsitinib | 0.0033113 | uM | 10 | 5000.00 | 2314.91 | 6773.00 | 6524.00 | 1.0382 | 1.0507 |